FULL AND PARTIAL AGONISTIC BEHAVIOR AND THERMODYNAMIC BINDING PARAMETERS OF ADENOSINE-A1-RECEPTOR LIGANDS

被引:32
作者
BOREA, PA
VARANI, K
DALPIAZ, A
CAPUZZO, A
FABBRI, E
IJZERMAN, AP
机构
[1] UNIV FERRARA,INST GEN PHYSIOL,I-44100 FERRARA,ITALY
[2] CTR BIOPHARMACEUT SCI,DIV MED CHEM,LEIDEN,NETHERLANDS
来源
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION | 1994年 / 267卷 / 01期
关键词
ADENOSINE-A1; RECEPTOR; INTRINSIC ACTIVITY; AGONISTS (FULL AND PARTIAL); RECEPTOR BINDING THERMODYNAMICS;
D O I
10.1016/0922-4106(94)90224-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The inhibitory effect of forskolin-stimulated 3',5'-cyclic monophosphate (c-AMP) synthesis in isolated rat adipocytes has been measured for eight typical adenosine receptor agonists. The percent inhibition was evaluated using concentrations of each compound corresponding to 100 times their K(i), inhibitory binding constants, determined in parallel by [H-3]N6-cyclohexyladenosine binding to adenosine A, receptors on adipocyte rat membranes which guaranteed full receptor occupancy. Some drugs were able to inhibit the forskolin-induced c-AMP accumulation by 100% (full agonists, intrinsic activity = 1) but others only to a lesser extent, ranging from 80% to 50% (partial agonists, intrinsic activities in the 0.8-0.5 interval). These efficacy data were correlated with the thermodynamic binding parameters (free energy, enthalpy and entropy) obtained in rat brain membranes by equilibrium constant measurements and van 't Hoff plots in the 0-degrees-30-degrees-C range. The positive correlation between intrinsic activity and entropy changes (r = 0.88, n = 8, P < 0.01) points to the possibility of obtaining information about the full spectrum of activities of adenosine analogues from in vitro binding assays and suggests some considerations on the possible drug-receptor interaction mechanism.
引用
收藏
页码:55 / 61
页数:7
相关论文
共 23 条
  • [1] Borea Pier Andrea, 1992, Molecular Neuropharmacology, V2, P273
  • [2] BROWN BL, 1972, ADV CYCL NUCL RES<D>, V2, P25
  • [3] CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
  • [4] CORNFIELD LJ, 1991, MOL PHARMACOL, V39, P780
  • [5] GILLI G, 1991, APPL CHARGE DENSITY, P241
  • [6] IJzerman A P, 1992, Drug Des Discov, V9, P49
  • [7] QUANTITATIVE-EVALUATION OF THE BETA-2-ADRENOCEPTOR AFFINITY OF PHENOXYPROPANOLAMINES AND PHENYLETHANOLAMINES
    IJZERMAN, AP
    AUE, GHJ
    BULTSMA, T
    LINSCHOTEN, MR
    TIMMERMAN, H
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1985, 28 (09) : 1328 - 1334
  • [8] QUANTITATIVE-EVALUATION OF THE BETA-2-ADRENOCEPTOR INTRINSIC ACTIVITY OF N-TERT-BUTYLPHENYLETHANOLAMINES
    IJZERMAN, AP
    BULTSMA, T
    TIMMERMAN, H
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (04) : 549 - 554
  • [9] KENAKIN TP, 1987, PHARM ANAL DRUG RECE
  • [10] LOHSE MJ, 1984, MOL PHARMACOL, V26, P1